About NeurAxis, Inc. 
NeurAxis, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 2 Schemes (1.63%)
Foreign Institutions
Held by 4 Foreign Institutions (3.39%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Dec 2025)
Net Profit:
-2 Million
Pharmaceuticals & Biotechnology
USD 75 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.80
-330.30%
32.87






